Your browser doesn't support javascript.
loading
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.
Espeseth, Amy S; Yuan, Maoli; Citron, Michael; Reiserova, Lucia; Morrow, Gavin; Wilson, Aaron; Horton, Melanie; Rukhman, Mark; Kinek, Keith; Hou, Fuxiang; Li, Shui L; Li, Fengsheng; Choi, Yesle; Heidecker, Gwen; Luo, Bin; Wu, Guoxin; Zhang, Lan; Strable, Erica; DeStefano, Joanne; Secore, Susan; Mukhopadhyay, Tarit K; Richardson, Douglas D; Sayeed, Eddy; Welch, Lisa S; Bett, Andrew J; Feinberg, Mark B; Gupta, Swati B; Cooper, Christopher L; Parks, Christopher L.
Afiliação
  • Espeseth AS; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Yuan M; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.
  • Citron M; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Reiserova L; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.
  • Morrow G; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.
  • Wilson A; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.
  • Horton M; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Rukhman M; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.
  • Kinek K; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Hou F; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.
  • Li SL; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.
  • Li F; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Choi Y; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.
  • Heidecker G; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Luo B; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Wu G; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Zhang L; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Strable E; Merck & Co., Inc., Rahway, New Jersey, USA.
  • DeStefano J; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.
  • Secore S; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Mukhopadhyay TK; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Richardson DD; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Sayeed E; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA.
  • Welch LS; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA; Currently at Clover Biopharmaceuticals, Boston, Massachusetts, USA.
  • Bett AJ; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Feinberg MB; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA.
  • Gupta SB; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA.
  • Cooper CL; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.
  • Parks CL; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA. Electronic address: cparks@iavi.org.
EBioMedicine ; 82: 104203, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35915046
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Animals / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Animals / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos